Disruption of gut microbiome and metabolome in treatment-naïve children with attention deficit hyperactivity disorder

Dingding Han1,2,3,4, Yuanyuan Zhang5, Wenxin Liu1,2

  • 1Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200062, China.

BMC Microbiology
|July 3, 2025
PubMed

Insights

Children with ADHD show gut bacteria imbalances and altered metabolites, particularly lower Bifidobacterium levels. This gut-brain axis connection may influence ADHD development and offers potential diagnostic and intervention targets.

Area of Science:

  • Neuroscience
  • Microbiology
  • Metabolomics

Background:

  • Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with increasing prevalence.
  • Emerging research suggests a role for gut microbiota in ADHD development.
  • The precise link between gut bacteria, metabolites, and ADHD in children is not well understood.

Purpose of the Study:

  • To investigate the fecal microbiome, metabolome, lipidome, and plasma metabolome in children with ADHD compared to healthy controls.
  • To identify specific microbial and metabolic alterations associated with ADHD.
  • To explore the relationship between gut microbiota and neurotransmitter pathways in ADHD.

Main Methods:

  • 16S rRNA gene sequencing for fecal microbiome analysis.
  • Liquid chromatography-mass spectrometry (LC-MS) for metabolome and lipidome profiling.
  • Comparison of 15 pairs of children with ADHD and healthy controls.

Main Results:

  • Children with ADHD exhibited gut microbiota imbalance and dysregulated metabolites.
  • Significantly lower abundance of Actinobacteria (e.g., Bifidobacterium) and higher Veillonella levels were observed in ADHD group.
  • ADHD patients were not classified under enterotype 1, which exclusively comprised healthy children.
  • Bifidobacterium genus, positively correlated with neurotransmitter precursor metabolites, may downregulate dopaminergic, serotonergic, and glutamatergic pathways.

Conclusions:

  • Gut microbiota significantly impacts ADHD development via metabolic pathways.
  • Findings suggest potential for gut microbiota-based diagnosis and intervention strategies for ADHD.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
310
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
205
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
312
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
325
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
74.2K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
399